Rigel to Present at the Jefferies Global Healthcare Conference in London | RIGL Stock News
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced that CEO Raul Rodriguez will present a company overview at the Jefferies Global Healthcare Conference in London on November 18, 2025, at 10:00 a.m. GMT. The presentation will be accessible via a live webcast on the company's Investor Relations website. Rigel focuses on developing therapies for hematologic disorders and cancer, and is based in South San Francisco, California.
, /PRNewswire/ -- Rigel Pharmaceuticals,Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025 at 10:00 a.m. GMT (5:00 a.m. ET).
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visitwww.rigel.com.
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com
Media:
David Rosen
Argot Partners
646.461.6387
david.rosen@argotpartners.com
SOURCE Rigel Pharmaceuticals, Inc.
